. 2017 Nov 7;18(11):2349. doi: 10.3390/ijms18112349

Table 4.

Analysis of the mRNA IGFBP (1, 2, 3 and 4) expression in VAT from the control and morbidly obese groups (LIR-MO and HIR-MO).

Gene	Control	LIR-MO	HIR-MO
IGFBP-1	5.61 ± 1.28 ^a	6.72 ± 2.21 ^ab	6.85 ± 2.39 ^ab
IGFBP-2	6.44 ± 1.11 ^a	11.29 ± 2.03 ^ab	10.03 ± 1.88 ^b
IGFBP-3	7.46 ± 1.08 ^a	10.03 ± 1.88 ^b	11.20 ± 1.60 ^b
IGFBP-4	4.23 ± 1.67 ^a	2.56 ± 1.42 ^ab	2.20 ± 1.03 ^ab

The results are given as the mean ± SD. Different letters indicate significant differences between the means of the different groups (a: controls vs. MO groups, b: LIR-MO vs. HIR-MO) (p < 0.01). LIR-MO: non-diabetic morbidly obese with low IR; HIR-MO: non-diabetic morbidly obese with high IR.